ArticleDrug design, development and therapy2016

Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.

Katharigatta N Venugopala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.